Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System, and our customers' success. Novanta's common shares are quoted on Nasdaq under the ticker symbol 'NOVT.'
More information about Novanta is available on the Company's website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025. Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Misled Investors Regarding its Business Operations. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) RP-A501 was less effective than defendants had led investors to believe; (2) to increase its effectiveness, Rocket Pharmaceuticals amended RP-A501's clinical trial protocol by introducing a novel immunomodulatory agent; (3) the foregoing increased the risk that patients would suffer from a Serious Adverse Event ('SAE'); (4) accordingly, RP-A501's safety, as well as its clinical, regulatory, and commercial prospects, were overstated; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. What Now: You may be eligible to participate in the class action against Rocket Pharmaceuticals, Inc. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 11, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome.
Yahoo
2 hours ago
- Yahoo
The Ocean Floor Could Power EVs. Will This Company Reap the Rewards?
Key Points The Metals Company is developing tech to harvest metal-rich nodules from the ocean floor. The company has no revenue and is still awaiting regulatory approval to begin mining. A recent U.S. permit application could offer The Metals Company an alternative path forward. 10 stocks we like better than TMC The Metals Company › Imagine diving into the Pacific Ocean's depths, not to see coral reefs or look for sunken pirate treasure, but to gather metal-dense rocks containing materials that can power the electric vehicle (EV) revolution. That, in a nutshell, is the bold vision of The Metals Company (NASDAQ: TMC), a Vancouver-based company aiming to vacuum polymetallic nodules from the seafloor. With a stock that had soared 430% in 2025 as of market close July 31, TMC has caught the eyes of investors betting on a future of green energy. But with no revenue, mounting losses, and a sea of risks, is this materials stock worth diving into? Let's explore. What does The Metals Company do? TMC isn't your typical mining stock. The company's core mission is to harvest polymetallic nodules from a remote stretch of Pacific Ocean known as the Clarion Clipperton Zone (CCZ). These lumpy, fist-sized seafloor stones are loaded with nickel, copper, cobalt, and manganese, all essential ingredients in everything from electric vehicle batteries to solar panels. On land, these rare earth metals are mined and processed in carbon-heavy ways, which ironically undercut the clean-tech future many are destined to be part of. TMC wants to flip the script. Instead of digging holes in the earth, it wants to scoop metal-rich nodules from the seabed and refine them into battery-grade materials, possibly with a lighter environmental footprint. The potential for TMC's mining operations is huge. As Henry Sanderson points out in his book Volt Rush: The Winners and Losers in the Race to Go Green, the deep sea holds more nickel, cobalt, and possibly other rare earth metals than all the world's land-based reserves combined. The CCZ alone is believed to contain some 21 billion metric tons of nodules -- enough raw material to not only shake China's grip on battery metals but supercharge the EV revolution for decades, if the materials can be gathered and refined. A big vision, but zero revenue But let's not sugarcoat it: TMC is nowhere near harvesting nodules at a commercial scale. The company reported zero revenue in the first quarter of 2025, paired with a net loss of about $20.6 million. That loss widened from $16.1 million in the quarter before. It turns out that building an underwater mining infrastructure from scratch isn't going to be cheap. Or quick. As of writing, TMC still doesn't have the green light to mine commercially in the CCZ. Although it holds exploration rights across two massive patches there, it doesn't yet have permission to start harvesting the goods. That authority rests with the International Seabed Authority (ISA), a United Nations-backed body that still hasn't finalized the regulatory playbook that companies like TMC need to operate. But there's a plot twist with the ISA: The U.S. never ratified the treaty that made the agency. While 169 nations and the European Union formally recognize the agency's authority, the U.S. isn't one of them. True, it does acknowledge parts of the treaty as international law, but technically, it's not bound by the ISA's rulebook. This means that if national interest comes into play -- say, securing domestic access to critical minerals -- the U.S. could try to go its own way. That would give companies like TMC a potential fast track to start operating in the CCZ. This is exactly the door that TMC is trying to walk through. In April 2025, the company filed a permit application under a decades-old U.S. law just days after President Donald Trump signed a U.S. executive order renewing interest in offshore critical minerals. If TMC's application is approved, it could mean mining under American jurisdiction in waters considered off-limits to the rest of the world. It's a long shot, legally speaking, and could breach international norms, but it would be a major breakthrough for a company with no revenue. A long-term wager with caveats TMC is what I'd call a moonshot (or, maybe a deep-sea Hail Mary) -- it's a big idea with big risks and potentially big payoffs. If the permits come through and the tech scales, today's price could look like a bargain. After all, a $2.65 billion market cap could look small compared to the multitrillion-dollar demand for battery metals that's expected over the next few decades. If TMC becomes even a minor supplier in that chain, its top-line growth could dwarf what investors are paying today. But if the ISA blocks its permit, or if U.S. jurisdiction doesn't hold up to legal scrutiny, or if other things turn out in ways not the best for the company, TMC could keep burning cash with no clear path to revenue. That's a lot of "ifs." Clearly, this isn't a stock for the risk-averse. For aggressive investors with long-term horizons, a small stake might make sense as part of a diversified portfolio. But I would wait for tangible progress, like a confirmed mining license, before scaling up exposure. Should you buy stock in TMC The Metals Company right now? Before you buy stock in TMC The Metals Company, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TMC The Metals Company wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Steven Porrello has positions in TMC The Metals Company. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. The Ocean Floor Could Power EVs. Will This Company Reap the Rewards? was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Nvidia CEO Jensen Huang Just Gave Meta Investors Great News -- or Did He?
Key Points Over the last several weeks, Meta has been offering top artificial intelligence (AI) researchers lucrative contracts. These people are now part of Meta Superintelligence Labs, a division focused on competing directly with OpenAI and others. Jensen Huang appears to be supportive of Meta's hiring strategy, but there's a catch. 10 stocks we like better than Meta Platforms › Every few decades, the technology world is reshaped by a generational visionary who somehow seems to see the future before it actually unfolds. Right now, the most important technologist might just be Jensen Huang, the CEO of Nvidia (NASDAQ: NVDA). Huang does not understand artificial intelligence (AI) purely from a technical perspective. The way he speaks about it is more cerebral. Beyond Huang, another technological visionary who is worth paying close attention to is Mark Zuckerberg, the CEO of Meta Platforms. Over the last several weeks, Meta has reportedly been on an aggressive hiring campaign, poaching top AI researchers from OpenAI, Alphabet, GitHub, and Apple. Huang recently addressed Meta's hiring strategy during a discussion at the All-In Summit, hosted by billionaire venture capitalist Chamath Palihapitiya. While Huang's comments about Meta sounded supportive overall, I think there are some key nuances to point out as Zuckerberg seeks to take on competition in the AI realm. Let's dig into Huang's comments and assess what could be in the cards for Meta investors. What did Huang just say about Meta? In a video clip shared on social media, Huang shares his thoughts around Meta's recent hiring spree and the reported hundred-million-dollar signing bonuses. Huang said that a team of roughly 150 researchers and appropriate funding could potentially go on to build a rival platform to OpenAI's ChatGPT. To back up his claim, he explained that several existing AI models that compete with ChatGPT were built by a team of similar size to what Zuckerberg is reportedly assembling through the creation of Meta Superintelligence Labs (MSL). On the surface, this sounds like Meta just earned a vote of confidence from Nvidia, once referred to as the "godfather of AI." But is that really the case? I think there might be more than meets the eye to Huang's comments. What Huang didn't say As a private company, OpenAI is not required to publish its financials or operating metrics. However, according to reports from CNBC, OpenAI now has 3 million paying enterprise customers and $10 billion in annual recurring revenue (ARR). To put this into perspective, OpenAI's ARR was estimated to be around $5.5 billion last year. Those numbers show the company has nearly doubled its ARR base in less than a year, underscoring OpenAI's ability to acquire customers and accelerate its growth trends despite intensified competition from other large language models (LLM) from Anthropic, DeepSeek, and Alphabet, for example. These nuances matter because Meta Superintelligence Labs won't just need to launch something, it will need to prove that it can weather challenges across product execution, customer acquisition, and competing with incumbents with strong first-mover advantages. Although Huang appears confident that more companies will introduce products that compete directly with OpenAI, I would say that his comments fall short of an explicit endorsement of Meta, per se. Rather, I think he's more simply implying that Meta has been investing strategically in its quest to conquer the AI landscape. Is Meta stock a buy now? As the chart below illustrates, Meta experienced sizable expansion in its price-to-earnings ratio (P/E) a couple of years ago. During this period, management implemented significant cost reductions, particularly in the metaverse division. It made a strategic decision to reallocate these savings into AI initiatives. Given the trends above, I'd say that investors welcomed the shift from the metaverse to AI and began pricing in some of the upside. However, over the last 18 months, Meta's P/E levels have pulled back considerably. In my eyes, this valuation reset suggests that investors may not fully appreciate the foundation that Zuckerberg and the management team laid a couple of years ago. In other words, the market may have prematurely bought up the stock, only to discount the long-term upside of the AI opportunity now. With the creation of Meta Superintelligence Labs and a roster of all-star talent ready to build and launch new AI-powered services, Meta could be on the cusp of a massive transformation that remains discounted from a valuation standpoint. At its current levels, I see Meta stock as a no-brainer buying opportunity at these prices as I think the company's upside from AI is largely discounted right now. Should you buy stock in Meta Platforms right now? Before you buy stock in Meta Platforms, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Meta Platforms wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Adam Spatacco has positions in Alphabet, Apple, Meta Platforms, and Nvidia. The Motley Fool has positions in and recommends Alphabet, Apple, Meta Platforms, and Nvidia. The Motley Fool has a disclosure policy. Nvidia CEO Jensen Huang Just Gave Meta Investors Great News -- or Did He? was originally published by The Motley Fool
